$256 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 63 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 71.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Buy | Celgene Corp | $18,335,000 | -7.6% | 205,522 | +8.2% | 7.15% | +2.3% |
| SHPG | Buy | Shire plcsponsored adr | $14,790,000 | +205.6% | 99,000 | +217.3% | 5.77% | +238.2% |
| ARRY | Buy | Array Biopharma Inc | $13,888,000 | +127.2% | 851,500 | +78.3% | 5.42% | +151.4% |
| NBIX | Buy | Neurocrine Biosciences Inc | $12,770,000 | +344.8% | 154,000 | +316.2% | 4.98% | +392.3% |
| SAGE | Buy | Sage Therapeutics Inc | $11,346,000 | +33.8% | 70,496 | +36.9% | 4.43% | +48.0% |
| GILD | Buy | Gilead Sciences Inc | $9,898,000 | +12.5% | 131,284 | +6.9% | 3.86% | +24.5% |
| ADMS | Buy | Adamas Pharmaceuticals Inc | $8,832,000 | -17.2% | 370,000 | +17.5% | 3.44% | -8.4% |
| HALO | Buy | Halozyme Therapeutics Inc | $7,026,000 | +22.8% | 358,633 | +26.9% | 2.74% | +35.8% |
| LGND | Buy | Ligand Pharmaceuticals Inc | $6,936,000 | +74.7% | 42,000 | +44.8% | 2.71% | +93.3% |
| IONS | Buy | Ionis Pharmaceuticals Inc | $5,576,000 | +115.4% | 126,500 | +145.6% | 2.18% | +138.2% |
| GTHX | Buy | G1 Therapeutics Inc | $3,813,000 | +393.3% | 103,000 | +164.1% | 1.49% | +444.7% |
| AGIO | Buy | Agios Pharmaceuticals Inc | $2,985,000 | +161.2% | 36,500 | +82.5% | 1.16% | +188.8% |
| JAZZ | New | Jazz Pharmaceuticals PLC | $2,867,000 | – | 19,000 | +100.0% | 1.12% | – |
| SGYPQ | Buy | Synergy Pharmaceuticals DEL | $2,726,000 | -18.8% | 1,505,809 | +0.0% | 1.06% | -10.2% |
| PBYI | Buy | Puma Biotechnology Inc | $2,312,000 | +94.9% | 34,000 | +183.3% | 0.90% | +115.8% |
| RARE | New | Ultragenyx Pharmaceutical Inc | $2,090,000 | – | 41,000 | +100.0% | 0.82% | – |
| AXGN | New | Axogen Inc | $1,823,000 | – | 50,000 | +100.0% | 0.71% | – |
| PEN | New | Penumbra Inc | $1,618,000 | – | 14,000 | +100.0% | 0.63% | – |
| XENT | New | Intersect Ent Inc | $1,452,000 | – | 37,000 | +100.0% | 0.57% | – |
| GMED | New | Globus Med Inc | $1,445,000 | – | 29,000 | +100.0% | 0.56% | – |
| MRUS | New | Merus N V | $1,391,000 | – | 75,060 | +100.0% | 0.54% | – |
| RIGL | New | Rigel Pharmaceuticals Inc | $1,302,000 | – | 370,000 | +100.0% | 0.51% | – |
| VSTM | New | Verastem Inc | $1,192,000 | – | 400,000 | +100.0% | 0.46% | – |
| ESPR | New | Esperion Therapeutics Inc | $723,000 | – | 10,000 | +100.0% | 0.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.